Stay Updated with the Latest Royalty Pharma plc RPRX News in Real Time
Find RPRX news now at Meyka AI. Stay informed with the latest Royalty Pharma plc stocks updates, including price news, market analysis, and expert insights.
Prince Harry Accuses UK of Withholding 2023 Al-Qaeda Threat Upon Return
Prince Harry claims UK security officials withheld a 2023 al-Qaeda threat. He returned to Britain last week and is demanding taxpayer-funded police protection for his family.
Sensex Rises 141 Points, Nifty Near 24,100 as IT Stocks Lead Friday’s Intraday Rally
The Sensex rose 141.12 points, or 0.18%, to 77,074.71 as of midday trading on Friday, August 28, 2026. The Nifty 50 added 11.60 points to trade at 24,102.45 during the same intraday window. IT stocks led the session as traders awaited Fed Chair Jerome Powell’s Jackson Hole address. These figures reflect an intraday snapshot around…
AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial
AstraZeneca said Thursday its drug Tezspire met all primary and secondary goals in a late-stage trial. The Phase III CROSSING trial tested Tezspire against placebo in eosinophilic oesophagitis (EoE). AstraZeneca developed the drug jointly with Amgen for this chronic inflammatory oesophagus condition. What the CROSSING Trial Showed The Phase III CROSSING trial evaluated two once-every-four-week…
IPO Subscription Today: Hy Tech Engineers Booked 114x, Skyways 14.4x and Symbiotec 13.86x
IPO subscription today has put Hy Tech Engineers in focus, with the issue reportedly booked 114 times on August 27, 2026. Skyways Air and Symbiotec Pharmalab also saw strong investor demand, with subscriptions of 14.4 times and 13.86 times, respectively. The wide gap between the three issues shows where investors are placing the strongest bets….
Japan’s Whistleblowers Face Retaliation: New Law Tightens Protections in December
Japan’s amended Whistleblower Protection Act, effective December 2026, shifts burden of proof to employers and adds criminal penalties. But gaps remain for harassment and demotion cases.
Strides Pharma Stock Rallies 10% as USFDA Concludes Bengaluru Inspection
Strides Pharma shares surged 11% to ₹1,055.90 on the BSE on August 20, 2026. The rally followed news that the company’s flagship Bengaluru facility received a USFDA Establishment Inspection Report. That report confirms successful closure of a cGMP inspection conducted in May 2026. Heavy trading volumes accompanied the sharp intraday move. What the USFDA EIR…
Schott Pharma (ETR: 1SXP) Shares Jump 4% as Barclays Upgrades Stock to Overweight on Growth Inflection
Schott Pharma shares jumped as much as 6.5% on August 18, 2026, hitting a new 52-week high of €23. Barclays upgraded the stock to “overweight” from “equal weight” and raised its price target to €27 from €16. Analyst Jonathon Unwin cited a genuine growth inflection after three years of declining earnings estimates. The upgrade reflects…
Gland Pharma (NSE: GLAND) Shares Surge 12% to 52-Week High of ₹2,969.90 After Strong Q1 FY27 Results
Gland Pharma shares jumped nearly 12% on August 11, 2026, hitting a fresh 52-week high of ₹2,969.90 after the company reported strong Q1 FY27 results. Revenue rose 19.5% year on year to ₹1,800 crore, while net profit surged 47% to ₹317 crore. Strong US sales and rising CDMO revenue supported the quarter. The sharp rise…
Goodwin Mulls Sale of Defence Engineering Division Supplying Submarine and Warship Components
On August 7, 2026, British engineering company Goodwin confirmed it is reviewing options for its defence engineering division, including the possible sale of a substantial part of the business. The division supplies critical components for UK and U.S. submarines and warships, making the announcement one of the most closely watched developments in the defence sector….